4.7 Article

Seven-year median time to progression with thalidomide for smoldering myeloma: partial response identifies subset requiring earlier salvage therapy for symptomatic disease

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma

Robert A. Kyle et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)

Article Oncology

International uniform response criteria for multiple myeloma

B. G. M. Durie et al.

LEUKEMIA (2006)

Article Medicine, General & Internal

A long-term study of prognosis in monoclonal gammopathy of undetermined significance

RA Kyle et al.

NEW ENGLAND JOURNAL OF MEDICINE (2002)

Review Oncology

Angiogenesis-dependent diseases

J Folkman

SEMINARS IN ONCOLOGY (2001)